GPS Wealth Strategies Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
GPS Wealth Strategies Group's ARKG Position: Q4 2025 in Review
GPS Wealth Strategies Group sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 62 shares — an estimated $1.72K sold.
GPS Wealth Strategies Group first reported a position in ARKG in Q1 2021 and held it in 18 quarters. The position peaked at $57K in Q2 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.
- GPS Wealth Strategies Group reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
- GPS Wealth Strategies Group sold 62 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $1.72K.
- GPS Wealth Strategies Group first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 18 quarters.
- GPS Wealth Strategies Group's ARK Genomic Revolution ETF position peaked at $57K in Q2 2021.
- 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.
Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.